By Staff
Wednesday, May 18, 2022 12:24 AM
ALEXANDRIA, Va.—The Vision Council today releases the Provider inSights Q1 2022 Report. The publication of the report continues the rollout of The Vision Council’s new
inSights Research Program.
By Staff
Tuesday, May 17, 2022 12:21 AM
PARIS—
Visionix and
Right MFG. Co., Ltd. announced yesterday that they have entered a long-term strategic partnership agreement, expected to accelerate growth for both companies. Visionix will become the exclusive partner of Right MFG, and distribute Righton products in Europe, the Americas and Asia Pacific (excluding Japan and China).
By Staff
Tuesday, May 17, 2022 12:18 AM
YAVNE, Israel—Belkin Vision, the Israel-based medical device company announced yesterday that it has been awarded CE Mark under Medical Device Regulation (MDR) from its notified body DEKRA, making it the first automated, non-contact glaucoma laser treatment available within Europe.
By Staff
Monday, May 16, 2022 12:24 AM
JENA, Germany—
Carl Zeiss Meditec generated revenue of €855.4 million in the first six months of the fiscal year ending March 31, 2022 versus €767.4 million the prior year, an 11.5 percent increase compared with the same period of the prior year (+10.7 percent adjusted for currency effects).
By Staff
Monday, May 16, 2022 12:15 AM
MIAMI, Fla.—
Bascom Palmer Eye Institute of the
University of Miami Miller School of Medicine announced that Meher Saleem has received a Research to Prevent Blindness (RPB) Medical Student Eye Research Fellowship that will allow her to take a year off from medical school and to devote that time to pursue a research project at Bascom Palmer. Saleem earned a bachelor of arts degree from the University of Miami, magna cum laude, with a double major in chemistry and studio art.
By Staff
Friday, May 13, 2022 12:27 AM
CHICAGO—
Prevent Blindness has declared May 16-22, 2022 as the third annual “Inherited Retinal Disease (IRD) Genetic Testing Week.” Educational materials, such as a fact sheet, social media graphics, and a dedicated webpage,
preventblindness.org/inherited-retinal-diseases/ are available. New this year to IRD Genetic Testing Week are two informational videos. Alina V. Dumitrescu, MD, clinical associate professor of ophthalmology and visual sciences, pediatric ophthalmology and strabismus, inherited eye disease at the University of Iowa hospitals and clinics, is featured in a new “IRD and Genetic Testing” episode in the Focus on Eye Health Expert Series.
By Staff
Thursday, May 12, 2022 12:18 AM
BRIDGEWATER, N.J.—
RVL Pharmaceuticals plc (Nasdaq: RVLP) announced that its FDA approved ptosis drug Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1% was selected as the winner of “Best Professional Treatment Product” in the “Shape Healthy Beauty Awards.”
By Staff
Wednesday, May 11, 2022 12:24 AM
ALEXANDRIA, Va.—
The Vision Council today releases the Consumer inSights Q1 2022 Report, the first published report from The Vision Council’s new
inSights Research Program, which was announced last week.
By Staff
Wednesday, May 11, 2022 12:21 AM
LAVAL, Quebec—
Bausch Health Companies Inc. (NYSE/TSX: BHC) yesterday reported $1.918 billion in total revenue for the first quarter of 2022, as compared to $2.027 billion in the first quarter of 2021, a decrease of $109 million, or 5 percent.
By Staff
Tuesday, May 10, 2022 12:26 PM
The COVID pandemic has led to a growing number of eye issues over the last two years which have been identified in a newly released
consumer survey conducted by
MyVision.org, a group of expert ophthalmologists and optometrists whose purpose is to provide trusted information on eye health and vision. Yesterday’s Data Feed featured some key findings from MyVision’s survey. Here are some additional highlights.
Driving, in general, is already dangerous, but what MyVision found about drivers with poor eyesight is especially concerning. One out of three drivers say they’ve driven with an outdated eyesight prescription.
By Staff
Tuesday, May 10, 2022 12:21 AM
SAN RAMON, Calif.—
CooperVision, a global leader in myopia management, has kicked off its 2022 Myopia Management Workshop series. The immersive full-day events are designed to accelerate practices’ clinical and business success in the fast-growing sector.
By Staff
Tuesday, May 10, 2022 12:15 AM
SYDNEY, Australia—
BHVI (Brien Holden Vision Institute), the Australian not-for-profit organization with an international focus on vision research, has announced the launch of Myopia Awareness Week for 2022, a global initiative relaunched in 2021, to bring attention to the growing epidemic of myopia in children across the world.
By Staff
Monday, May 9, 2022 12:50 PM
The COVID pandemic has led to a growing number of eye issues over the last two years, according to the results of a new
consumer survey conducted by
MyVision.org, a group of expert ophthalmologists and optometrists whose purpose is to provide trusted information on eye health and vision. The organization polled more than 1,121 people who wear glasses and/or contacts to get feedback on their eye health and eye habits throughout the past few years.
By Staff
Monday, May 9, 2022 12:18 AM
LAKE FOREST, Calif.—
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, reported record net sales of $63.2 million for the first quarter ended April 1, 2022, a 25 percent increase over the prior year quarter.
By Staff
Friday, May 6, 2022 12:24 AM
BANGKOK—
Hoya Vision Care announced yesterday that it has obtained positive results from a six-year clinical study of its MiYoSmart spectacle lens with Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. The research findings were shared at the
Association for Research in Vision and Ophthalmology (ARVO) 2022 conference in Denver, Colo. by Professor Carly Lam from the Centre for Myopia Research at
The Hong Kong Polytechnic University. Professor Lam conducted the research, which is the longest study on a myopia management spectacle lens to date.